Opti3 Omega 3 Analytical Study Results Announced

Nottingham, United Kingdom, February 19, 2013 --(PR.com)-- A recent analytical testing study by ESB Developments Limited in the UK found that the Omega3 content of there Opti3 Capsules was higher than many branded fish oil and algal oil capsules sold in the UK.

Opti3 contains over 700mg EPA & DHA per dose which was double that of many other leading branded Omega 3 supplements including those from Boots, Holland and Barrett and Vitabiotic omega 3 capsule products. Omega 3 EPA & DHA fatty acids are the nutrients which have been shown in many clinical studies to provide the many health benefits associated with omega 3 including cardiovascular, joint and cognitive support.

Crucially Opti3 Omega 3 Capsules were also found to have a much lower peroxide value compared to fish oil capsules which is a key indicator for oil quality and its overall stability.

Commenting on the study results Marketing Director Chris Smith said, "The testing results show Opti3 is a high quality EPA & DHA formula but also demonstrates Opti3 is great value to the consumer given such a high dose of omega 3 per dose."

Uniquely Opti3 capsules are not derived from gelatin they are 100% plant based which has found excellent resonance with consumers who prefer ingredients they can trust and ensure are safe.

Opti3 is sold on the web and from selected retailers in the UK and overseas for further details see www.opti3omega.com